Skip to main content
NVDA-0.32%AAPL-1.76%GOOGL+1.65%MSFT+2.37%AMZN+2.78%TSM-1.67%SPCX+1.33%META+0.51%AVGO+0.77%TSLA+2.20%SKHY-0.01%MU-0.62%BRK-B+0.84%LLY+0.60%AMD-1.58%JPM+0.44%WMT+0.55%V+2.58%XOM+0.67%ASMLa-1.84%JNJ+1.62%INTC-1.26%MA+2.09%0700.HK+3.26%ABBV+1.78%CSCO+2.14%1398.HK-0.92%CVX+0.74%COST-0.46%AMAT+0.12%AP2d-2.02%ORCL+4.68%LRCX+0.06%DELL+0.25%BAC+0.79%KO+0.32%CAT+0.46%PG+0.17%UNH+1.71%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%HSBA.L+1.10%GE+0.31%PM-0.05%0857.HK0.00%0939.HK+0.83%NFLX-1.10%MS+0.88%1288.HK-1.52%NZDMXN+1.45%USDMXN+1.38%EURAUD-0.87%AUDJPY+0.67%AUDCHF+0.59%EURUSD-0.56%EURZAR-0.56%USDPLN+0.50%CHFSEK+0.50%AUDCAD+0.48%EURGBP-0.46%GBPAUD-0.45%AUDDKK+0.45%USDTRY+0.44%EURNZD-0.44%AUDNZD+0.43%GBPTRY+0.41%EURCAD-0.39%EURCHF-0.38%GBPZAR-0.38%USDZAR-0.36%EURCNH-0.34%USDSEK+0.34%AUDNOK+0.33%GBPHKD+0.32%AUDUSD+0.32%AUDSGD+0.31%USDJPY+0.31%EURPLN+0.30%GBPMXN-0.28%EURJPY-0.28%SGDJPY+0.23%CHFNOK+0.23%PLNJPY-0.23%CHFSGD+0.22%NOKJPY+0.21%EURHKD-0.20%USDDKK+0.20%NZDJPY+0.19%USDCHF+0.19%GBPJPY+0.19%USDCAD+0.18%USDILS+0.16%USDCNH-0.16%EURSGD-0.14%EURNOK-0.14%EURSEK+0.13%CADJPY+0.12%NZDSGD+0.12%NZDUSD-0.12%CHFJPY+0.11%GBPUSD-0.10%EURCZK+0.08%GBPCHF+0.08%NZDCHF+0.08%GBPCAD+0.08%NZDCAD+0.07%USDNOK+0.07%USDSGD+0.06%USDCOP-0.04%GBPSGD+0.04%GBPNZD+0.01%USDHKD+0.01%EURDKK-0.01%CADCHF+0.01%USDTHB0.00%C1-5.65%XNGUSD+3.12%W1-2.86%XAGUSD+2.60%GAGUSD+2.60%XPTUSD+2.46%HG1+2.13%S1-1.48%XAUUSD+1.30%GAUUSD+1.30%COCOA+0.94%COFFEE-0.70%BTCUSD+1.30%ETHUSD+16.31%USDTUSD0.00%XRPUSD+8.70%SOLUSD+8.05%TRXUSDT0.00%ZECUSDT+2.60%DOGEUSD+11.60%XMRUSDT-2.15%LINKUSD+12.58%XLMUSD+0.50%BCHUSDT+1.36%LTCUSD+5.93%UNIUSD+3.31%SUIUSD+2.11%HBARUSDT+0.84%TONUSD+24.22%TAOUSDT+2.57%AAVEUSD+2.53%DOTUSDT+10.38%ICPUSDT+3.85%ONDOUSDT+0.91%WLDUSDT+3.49%JUPUSDT+12.99%ARBUSDT+5.20%ATOMUSDT+14.37%STXUSDT+0.42%INJUSDT+2.61%FETUSDT+0.84%PYTHUSDT+3.95%SEIUSDT-0.89%TIAUSDT-4.89%IMXUSDT-0.22%GRTUSDT+2.78%OPUSDT+7.19%IOTAUSDT+0.96%WIFUSDT+2.12%AXSUSDT+1.16%POLUSDT+2.58%FARTCOINUSDT-0.65%EOSUSDT+4.11%DYDXUSDT+4.23%GALAUSDT+1.47%ORDIUSDT+0.22%RONINUSDT+2.73%NOTUSDT+3.72%NVDA-0.32%AAPL-1.76%GOOGL+1.65%MSFT+2.37%AMZN+2.78%TSM-1.67%SPCX+1.33%META+0.51%AVGO+0.77%TSLA+2.20%SKHY-0.01%MU-0.62%BRK-B+0.84%LLY+0.60%AMD-1.58%JPM+0.44%WMT+0.55%V+2.58%XOM+0.67%ASMLa-1.84%JNJ+1.62%INTC-1.26%MA+2.09%0700.HK+3.26%ABBV+1.78%CSCO+2.14%1398.HK-0.92%CVX+0.74%COST-0.46%AMAT+0.12%AP2d-2.02%ORCL+4.68%LRCX+0.06%DELL+0.25%BAC+0.79%KO+0.32%CAT+0.46%PG+0.17%UNH+1.71%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%HSBA.L+1.10%GE+0.31%PM-0.05%0857.HK0.00%0939.HK+0.83%NFLX-1.10%MS+0.88%1288.HK-1.52%NZDMXN+1.45%USDMXN+1.38%EURAUD-0.87%AUDJPY+0.67%AUDCHF+0.59%EURUSD-0.56%EURZAR-0.56%USDPLN+0.50%CHFSEK+0.50%AUDCAD+0.48%EURGBP-0.46%GBPAUD-0.45%AUDDKK+0.45%USDTRY+0.44%EURNZD-0.44%AUDNZD+0.43%GBPTRY+0.41%EURCAD-0.39%EURCHF-0.38%GBPZAR-0.38%USDZAR-0.36%EURCNH-0.34%USDSEK+0.34%AUDNOK+0.33%GBPHKD+0.32%AUDUSD+0.32%AUDSGD+0.31%USDJPY+0.31%EURPLN+0.30%GBPMXN-0.28%EURJPY-0.28%SGDJPY+0.23%CHFNOK+0.23%PLNJPY-0.23%CHFSGD+0.22%NOKJPY+0.21%EURHKD-0.20%USDDKK+0.20%NZDJPY+0.19%USDCHF+0.19%GBPJPY+0.19%USDCAD+0.18%USDILS+0.16%USDCNH-0.16%EURSGD-0.14%EURNOK-0.14%EURSEK+0.13%CADJPY+0.12%NZDSGD+0.12%NZDUSD-0.12%CHFJPY+0.11%GBPUSD-0.10%EURCZK+0.08%GBPCHF+0.08%NZDCHF+0.08%GBPCAD+0.08%NZDCAD+0.07%USDNOK+0.07%USDSGD+0.06%USDCOP-0.04%GBPSGD+0.04%GBPNZD+0.01%USDHKD+0.01%EURDKK-0.01%CADCHF+0.01%USDTHB0.00%C1-5.65%XNGUSD+3.12%W1-2.86%XAGUSD+2.60%GAGUSD+2.60%XPTUSD+2.46%HG1+2.13%S1-1.48%XAUUSD+1.30%GAUUSD+1.30%COCOA+0.94%COFFEE-0.70%BTCUSD+1.30%ETHUSD+16.31%USDTUSD0.00%XRPUSD+8.70%SOLUSD+8.05%TRXUSDT0.00%ZECUSDT+2.60%DOGEUSD+11.60%XMRUSDT-2.15%LINKUSD+12.58%XLMUSD+0.50%BCHUSDT+1.36%LTCUSD+5.93%UNIUSD+3.31%SUIUSD+2.11%HBARUSDT+0.84%TONUSD+24.22%TAOUSDT+2.57%AAVEUSD+2.53%DOTUSDT+10.38%ICPUSDT+3.85%ONDOUSDT+0.91%WLDUSDT+3.49%JUPUSDT+12.99%ARBUSDT+5.20%ATOMUSDT+14.37%STXUSDT+0.42%INJUSDT+2.61%FETUSDT+0.84%PYTHUSDT+3.95%SEIUSDT-0.89%TIAUSDT-4.89%IMXUSDT-0.22%GRTUSDT+2.78%OPUSDT+7.19%IOTAUSDT+0.96%WIFUSDT+2.12%AXSUSDT+1.16%POLUSDT+2.58%FARTCOINUSDT-0.65%EOSUSDT+4.11%DYDXUSDT+4.23%GALAUSDT+1.47%ORDIUSDT+0.22%RONINUSDT+2.73%NOTUSDT+3.72%
ML

Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ • Healthcare

$7.21
-$0.21 (-3.0%)
Market open

Last close at October 8, 2026 at 20:00 UTC

Open$7.31
Previous Close$7.21
Day Range$7.01 - $7.37
Avg. Volume (3M)2.7M
Market Cap$2B
52 Week Range
$2.55$9.42
Next EarningsIn 27 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$51.4M100%
Gross Profitminus cost of goods$20.6M40%

In plain terms: out of every $100 in revenue, Maravai LifeSciences Holdings, Inc. currently loses $24.

Fundamentals & Financials

Revenue (TTM)
$208.7M
Net Income (TTM)
-$77.3M
EPS (TTM)
-$0.54
ROA (TTM)
-12.82%
Current Ratio
4.05

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+42.9%Q1 2026-$0.04
+120.0%Q2 2026$0.01
+54.1%Q3 2026-$0.02
Next

Nov 5

in 27 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Maravai LifeSciences Holdings, Inc. (MRVI) reports next on November 5, 2026. Wall Street is looking for consensus EPS of -$0.056 on revenue of $43.6 million; as trailing context, revenue grew +8.5% year over year last quarter. MRVI has beaten EPS in 3 of its 8 most recent quarters, keeping focus on profitability progress and demand trends.

View full earnings history

About Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc. develops and supplies biotechnology products used in research, diagnostics, and therapeutic manufacturing. Listed on NASDAQ as MRVI, the company operates across the healthcare sector through nucleic acid and biologics testing offerings, and it recorded $185.7 million in revenue in FY2025.

Name
Maravai LifeSciences Holdings, Inc.
CEO
Bernd Brust
Website
www.maravai.com
Industry
Healthcare
Employees
415

Today's Snapshot

AI-generated

MRVI opened slightly higher at 7.23, in line with a firmer sector.

Trading Volume

Below 10d avg (2.8M)

274.6K

vs S&P 500 Today

Outperforming Market

+1.69%

Updated: October 9, 2026 at 14:42 UTC

MRVI Headlines

Maravai lifts 2026 outlook after strong Q1

May 9, 2026

3 min read
View All News

Technical Indicators

3 Buy3 Neutral2 Sell
MRVI’s technical profile leans constructive because price sits above the 50-, 100- and 200-day averages even though it trades under the short 10–20 day lines, creating a short-term pullback within a longer-term uptrend. Momentum is muted overall, with RSI near neutral, MACD flat and Williams %R in oversold territory, while ADX indicates only moderate directional strength. Volatility is notable relative to price per the ATR, and on-balance volume readings are mixed. The pivot around 7.20 acts as a nearby technical reference. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$5.29 - $7.55
    Buy
  • RSI (14)47.98
    Neutral
  • Stochastic %K (14, 3, 3)21.50
    Neutral
  • MACD Level (12, 26)0.11
    Neutral

Peers & Related Assets

TECHBio-Techne Corporation
$72.45-0.1%
BIOBio-Rad Laboratories, Inc.
$360.4-2.0%
RGENRepligen Corporation
$163.84-2.0%
NEOGNeogen Corporation
$11.71+0.3%
BLFSBioLife Solutions, Inc.
$38.61+3.5%
AZTAAzenta, Inc.
$36+0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.